Global Sertraline Market Growth 2019-2024

Published On: Jan 2019

Format: PDF

Publisher: LP Infomation

Pages: 132

Report ID: 224516

Sertraline is an antidepressant used to treat depression, obsessive-compulsive disorder, panic disorder and anxiety.

According to this study, over the next five years the Sertraline market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Sertraline business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Sertraline market by product type, application, key manufacturers and key regions and countries.

This study considers the Sertraline value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.
Tablet
Oral Concentrate
Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.
Adult
Children

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Teva
Mylan
APOTEX
Aurobindo Pharma
Lupin Pharmaceuticals
Torrent Pharmaceuticals
Sun Pharmaceutical
Oxford Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Sertraline consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.
To understand the structure of Sertraline market by identifying its various subsegments.
Focuses on the key global Sertraline manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sertraline with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Sertraline submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Sertraline Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sertraline Consumption 2013-2023
2.1.2 Sertraline Consumption CAGR by Region
2.2 Sertraline Segment by Type
2.2.1 Tablet
2.2.2 Oral Concentrate
2.3 Sertraline Consumption by Type
2.3.1 Global Sertraline Consumption Market Share by Type (2013-2018)
2.3.2 Global Sertraline Revenue and Market Share by Type (2013-2018)
2.3.3 Global Sertraline Sale Price by Type (2013-2018)
2.4 Sertraline Segment by Application
2.4.1 Adult
2.4.2 Children
2.5 Sertraline Consumption by Application
2.5.1 Global Sertraline Consumption Market Share by Application (2013-2018)
2.5.2 Global Sertraline Value and Market Share by Application (2013-2018)
2.5.3 Global Sertraline Sale Price by Application (2013-2018)

3 Global Sertraline by Players
3.1 Global Sertraline Sales Market Share by Players
3.1.1 Global Sertraline Sales by Players (2016-2018)
3.1.2 Global Sertraline Sales Market Share by Players (2016-2018)
3.2 Global Sertraline Revenue Market Share by Players
3.2.1 Global Sertraline Revenue by Players (2016-2018)
3.2.2 Global Sertraline Revenue Market Share by Players (2016-2018)
3.3 Global Sertraline Sale Price by Players
3.4 Global Sertraline Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Sertraline Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Sertraline Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Sertraline by Regions
4.1 Sertraline by Regions
4.1.1 Global Sertraline Consumption by Regions
4.1.2 Global Sertraline Value by Regions
4.2 Americas Sertraline Consumption Growth
4.3 APAC Sertraline Consumption Growth
4.4 Europe Sertraline Consumption Growth
4.5 Middle East & Africa Sertraline Consumption Growth

5 Americas
5.1 Americas Sertraline Consumption by Countries
5.1.1 Americas Sertraline Consumption by Countries (2013-2018)
5.1.2 Americas Sertraline Value by Countries (2013-2018)
5.2 Americas Sertraline Consumption by Type
5.3 Americas Sertraline Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Sertraline Consumption by Countries
6.1.1 APAC Sertraline Consumption by Countries (2013-2018)
6.1.2 APAC Sertraline Value by Countries (2013-2018)
6.2 APAC Sertraline Consumption by Type
6.3 APAC Sertraline Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Sertraline by Countries
7.1.1 Europe Sertraline Consumption by Countries (2013-2018)
7.1.2 Europe Sertraline Value by Countries (2013-2018)
7.2 Europe Sertraline Consumption by Type
7.3 Europe Sertraline Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Sertraline by Countries
8.1.1 Middle East & Africa Sertraline Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Sertraline Value by Countries (2013-2018)
8.2 Middle East & Africa Sertraline Consumption by Type
8.3 Middle East & Africa Sertraline Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Sertraline Distributors
10.3 Sertraline Customer

11 Global Sertraline Market Forecast
11.1 Global Sertraline Consumption Forecast (2018-2023)
11.2 Global Sertraline Forecast by Regions
11.2.1 Global Sertraline Forecast by Regions (2018-2023)
11.2.2 Global Sertraline Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Sertraline Forecast by Type
11.8 Global Sertraline Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Details
12.1.2 Sertraline Product Offered
12.1.3 Pfizer Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Pfizer News
12.2 Teva
12.2.1 Company Details
12.2.2 Sertraline Product Offered
12.2.3 Teva Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Teva News
12.3 Mylan
12.3.1 Company Details
12.3.2 Sertraline Product Offered
12.3.3 Mylan Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Mylan News
12.4 APOTEX
12.4.1 Company Details
12.4.2 Sertraline Product Offered
12.4.3 APOTEX Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 APOTEX News
12.5 Aurobindo Pharma
12.5.1 Company Details
12.5.2 Sertraline Product Offered
12.5.3 Aurobindo Pharma Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Aurobindo Pharma News
12.6 Lupin Pharmaceuticals
12.6.1 Company Details
12.6.2 Sertraline Product Offered
12.6.3 Lupin Pharmaceuticals Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Lupin Pharmaceuticals News
12.7 Torrent Pharmaceuticals
12.7.1 Company Details
12.7.2 Sertraline Product Offered
12.7.3 Torrent Pharmaceuticals Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Torrent Pharmaceuticals News
12.8 Sun Pharmaceutical
12.8.1 Company Details
12.8.2 Sertraline Product Offered
12.8.3 Sun Pharmaceutical Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Sun Pharmaceutical News
12.9 Oxford Pharma
12.9.1 Company Details
12.9.2 Sertraline Product Offered
12.9.3 Oxford Pharma Sertraline Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Oxford Pharma News

13 Research Findings and Conclusion